MXCT
MaxCyte, Inc. · Healthcare
EVP, Global Sales, Marketing Thomas M. Ross sold $202K of MaxCyte, Inc.
Sold$201,670
$6.92Price
29,133Shares
−100%Stake
What MXCT did after the filing
- The stock from Thu, Nov 3 close, $6.70
- −20.3%
- S&P 500, same days
- +3.8%
Measured over 30 trading days, to the Dec 16 close.
Traded Tue, Nov 1. Filed Thu, Nov 3, 12:53 PM ET, during the session. Returns use the Nov 3 close and the Dec 16 close. Not investment advice.